Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
The Journal of Prosthetic Dentistry
|
November 1, 1974
Inherent structural defects of porcelain-fused-to-gold restorations: a preliminary report
V W Mintz, A A Caputo, C M Belting
Archives of Biochemistry and Biophysics
|
May 23, 2001
Expression of a functional proteinase inhibitor capable of accepting xylose: bikunin
C Falkenberg, L Wester, M Belting, et al.
Glycobiology
|
March 1, 1996
Heparan sulphate/heparin glycosaminoglycans with strong affinity for the growth-promoter spermine have high antiproliferative activity
M Belting, B Havsmark, M Jönsson, et al.
Glycobiology
|
May 18, 2000
A novel role for nitric oxide in the endogenous degradation of heparan sulfate during recycling of glypican-1 in vascular endothelial cells
K Mani, M Jönsson, G Edgren, et al.
The Journal of Biological Chemistry
|
September 29, 2001
Modulations of glypican-1 heparan sulfate structure by inhibition of endogenous polyamine synthesis. Mapping of spermine-binding sites and heparanase, heparin lyase, and nitric oxide/nitrite cleavage sites
K Ding, S Sandgren, K Mani, et al.
Matrix Biology : Journal of the International Society for Matrix Biology
|
August 30, 2000
Biosynthesis of decorin and glypican
L A Fransson, M Belting, M Jönsson, et al.
The Journal of Biological Chemistry
|
December 9, 2000
N-unsubstituted glucosamine in heparan sulfate of recycling glypican-1 from suramin-treated and nitrite-deprived endothelial cells. mapping of nitric oxide/nitrite-susceptible glucosamine residues to clustered sites near the core protein
K Ding, M Jonsson, K Mani, et al.
Cellular and Molecular Life Sciences : CMLS
|
April 28, 2004
Novel aspects of glypican glycobiology
L-A Fransson, M Belting, F Cheng, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 22, 2019
Low-molecular-weight heparin adherence and effects on survival within a randomised phase III lung cancer trial (RASTEN)
E Gezelius, P O Bendahl, K Gonçalves de Oliveira, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 7, 2017
Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer: the RASTEN trial
L Ek, E Gezelius, B Bergman, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
The Journal of Prosthetic Dentistry
|
November 1, 1974
Inherent structural defects of porcelain-fused-to-gold restorations: a preliminary report
V W Mintz, A A Caputo, C M Belting
Archives of Biochemistry and Biophysics
|
May 23, 2001
Expression of a functional proteinase inhibitor capable of accepting xylose: bikunin
C Falkenberg, L Wester, M Belting, et al.
Glycobiology
|
March 1, 1996
Heparan sulphate/heparin glycosaminoglycans with strong affinity for the growth-promoter spermine have high antiproliferative activity
M Belting, B Havsmark, M Jönsson, et al.
Glycobiology
|
May 18, 2000
A novel role for nitric oxide in the endogenous degradation of heparan sulfate during recycling of glypican-1 in vascular endothelial cells
K Mani, M Jönsson, G Edgren, et al.
The Journal of Biological Chemistry
|
September 29, 2001
Modulations of glypican-1 heparan sulfate structure by inhibition of endogenous polyamine synthesis. Mapping of spermine-binding sites and heparanase, heparin lyase, and nitric oxide/nitrite cleavage sites
K Ding, S Sandgren, K Mani, et al.
Matrix Biology : Journal of the International Society for Matrix Biology
|
August 30, 2000
Biosynthesis of decorin and glypican
L A Fransson, M Belting, M Jönsson, et al.
The Journal of Biological Chemistry
|
December 9, 2000
N-unsubstituted glucosamine in heparan sulfate of recycling glypican-1 from suramin-treated and nitrite-deprived endothelial cells. mapping of nitric oxide/nitrite-susceptible glucosamine residues to clustered sites near the core protein
K Ding, M Jonsson, K Mani, et al.
Cellular and Molecular Life Sciences : CMLS
|
April 28, 2004
Novel aspects of glypican glycobiology
L-A Fransson, M Belting, F Cheng, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 22, 2019
Low-molecular-weight heparin adherence and effects on survival within a randomised phase III lung cancer trial (RASTEN)
E Gezelius, P O Bendahl, K Gonçalves de Oliveira, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 7, 2017
Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer: the RASTEN trial
L Ek, E Gezelius, B Bergman, et al.
Page
of 3